Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Assets Average (2021 - 2023)

Historic Assets Average for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to $508.3 million.

  • Cullinan Therapeutics' Assets Average fell 2084.84% to $508.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $508.3 million, marking a year-over-year decrease of 2084.84%. This contributed to the annual value of $499.2 million for FY2022, which is 5313.89% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Assets Average stood at $508.3 million for Q3 2023, which was down 2084.84% from $518.5 million recorded in Q2 2023.
  • Cullinan Therapeutics' Assets Average's 5-year high stood at $642.2 million during Q3 2022, with a 5-year trough of $347.2 million in Q1 2021.
  • For the 3-year period, Cullinan Therapeutics' Assets Average averaged around $500.9 million, with its median value being $508.3 million (2023).
  • As far as peak fluctuations go, Cullinan Therapeutics' Assets Average skyrocketed by 3995.93% in 2022, and later tumbled by 2084.84% in 2023.
  • Over the past 3 years, Cullinan Therapeutics' Assets Average (Quarter) stood at $445.3 million in 2021, then soared by 32.31% to $589.2 million in 2022, then dropped by 13.72% to $508.3 million in 2023.
  • Its Assets Average was $508.3 million in Q3 2023, compared to $518.5 million in Q2 2023 and $538.1 million in Q1 2023.